Stem Cell Research

Scope & Guideline

Unlocking the mysteries of stem cell biology.

Introduction

Immerse yourself in the scholarly insights of Stem Cell Research with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1873-5061
PublisherELSEVIER
Support Open AccessYes
CountryNetherlands
TypeJournal
Convergefrom 2007 to 2024
AbbreviationSTEM CELL RES / Stem Cell Res.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The journal 'Stem Cell Research' focuses on advancing scientific knowledge in the field of stem cell biology, emphasizing the generation and application of induced pluripotent stem cells (iPSCs) and their use in modeling diseases, regenerative medicine, and therapeutic development.
  1. Induced Pluripotent Stem Cells (iPSCs) Generation:
    The core focus of the journal is the generation of iPSC lines from various sources, including patients with specific genetic disorders, healthy donors, and other model organisms. This includes the application of advanced techniques such as CRISPR/Cas9 for gene editing.
  2. Disease Modeling:
    The journal frequently publishes research on the use of iPSCs to model a wide array of diseases, including neurodegenerative disorders, cardiac conditions, metabolic diseases, and genetic syndromes, providing insights into disease mechanisms and potential treatments.
  3. Therapeutic Applications:
    Research articles often explore the therapeutic implications of iPSCs, including their differentiation into specific cell types for transplantation and their use in drug screening and development.
  4. Ethnic and Genetic Diversity in Stem Cell Research:
    The journal highlights the importance of genetic diversity by publishing studies that include iPSC lines derived from diverse ethnic backgrounds and genetic profiles, aiming to enhance the applicability of stem cell therapies across different populations.
  5. Technological Innovations:
    Innovations in stem cell technologies, such as non-integrative reprogramming methods, advanced gene editing techniques, and the development of novel reporter lines for tracking differentiation and function, are also emphasized.
The journal 'Stem Cell Research' has demonstrated a dynamic evolution in its focus, with several emerging themes gaining traction. These trends reflect the ongoing advancements in stem cell technologies and their applications in various fields.
  1. CRISPR/Cas9 and Gene Editing:
    The use of CRISPR/Cas9 technology for gene editing in iPSCs is a rapidly growing area, with numerous studies focusing on creating specific gene knockouts or corrections to model diseases more accurately and develop potential therapies.
  2. Personalized Medicine and Patient-Derived iPSCs:
    There is a significant increase in research dedicated to generating patient-specific iPSCs for personalized medicine applications, particularly for diseases like Alzheimer's, Parkinson's, and various genetic disorders.
  3. Applications in Regenerative Medicine:
    Research that explores the application of iPSCs in regenerative medicine, including tissue engineering and organoid development, is on the rise, highlighting the potential for using iPSCs in clinical therapies.
  4. Mental Health and Neurological Disorders:
    The journal has seen an increase in studies focusing on the use of iPSCs to model mental health disorders, such as schizophrenia and autism, reflecting a growing interest in understanding the neurological basis of these conditions.
  5. Ethnic Diversity in Stem Cell Research:
    Emerging themes include the generation of iPSC lines from diverse ethnic groups to address health disparities and improve the applicability of stem cell therapies across different populations.

Declining or Waning

While 'Stem Cell Research' covers a broad spectrum of topics, certain areas have shown signs of declining interest or publication frequency over recent years. These waning scopes may reflect shifts in research priorities or advancements in technology that have rendered certain approaches less relevant.
  1. Adult Stem Cell Research:
    There has been a notable decrease in publications focusing solely on adult stem cells compared to iPSCs. This shift indicates a greater emphasis on iPSCs due to their versatility and the ability to generate patient-specific cell lines.
  2. Basic Stem Cell Biology:
    Research centered around the fundamental biology of stem cells, such as stem cell niche interactions and basic pluripotency mechanisms, appears to be waning as the field moves toward more applied research in disease modeling and therapy.
  3. Non-human Stem Cell Models:
    There has been a decline in papers utilizing non-human stem cell models (e.g., mouse or primate models) in favor of human-derived iPSCs, reflecting a trend towards research that is more directly applicable to human health.
  4. Stem Cell Banking and Ethics:
    Discussions and publications related to stem cell banking practices and the ethical implications of stem cell research have become less prominent, possibly due to the increasing normalization of iPSC research and clinical applications.

Similar Journals

Regenerative Engineering and Translational Medicine

Unveiling New Horizons in Cell Biology and Engineering
Publisher: SPRINGER HEIDELBERGISSN: 2364-4133Frequency: 4 issues/year

Regenerative Engineering and Translational Medicine is an esteemed academic journal published by Springer Heidelberg, focusing on the interdisciplinary fields of biomaterials, biomedical engineering, and cell biology. With an ISSN of 2364-4133 and an E-ISSN of 2364-4141, the journal has carved a niche for itself since its inception in 2015, showcasing cutting-edge research that bridges the gap between scientific findings and practical applications in regenerative medicine. As a recognized platform in its field, it is currently positioned within Q3 quartiles in biomaterials, biomedical engineering, and medicine (miscellaneous), with a Scopus ranking that reflects its growing influence among peers. The journal aims to disseminate high-quality, peer-reviewed articles that highlight advancements in regenerative engineering, further advancing both theoretical and applied research. Scholars and practitioners seeking to stay at the forefront of the ever-evolving landscape of regenerative health solutions will find invaluable insights and innovations within these pages. Join a community of leading thinkers and explore the journal's comprehensive research contributions, which are crucial for fostering partnerships between academia and industry in the quest for transformative medical solutions.

Stem Cells International

Connecting Researchers to Transform Stem Cell Science
Publisher: HINDAWI LTDISSN: 1687-966XFrequency:

Stem Cells International is a premier open access journal published by HINDAWI LTD, focusing on the rapidly evolving field of stem cell research. With an ISSN of 1687-966X and E-ISSN 1687-9678, this journal has been a vital resource since its inception in 2010, showcasing innovative studies and breakthroughs up to 2024. Positioned in Q3 in Cell Biology and Q2 in Molecular Biology for 2023, as well as well-ranked in the Scopus database, the journal serves as an essential platform for researchers, professionals, and students dedicated to exploring the implications of stem cell technology in regenerative medicine and biological research. The open access model ensures wide accessibility, fostering collaboration and knowledge-sharing across the scientific community, making it a cornerstone in advancing the understanding and application of stem cell science.

Russian Journal of Developmental Biology

Connecting past insights with future breakthroughs.
Publisher: PLEIADES PUBLISHING INCISSN: 1062-3604Frequency: 6 issues/year

The Russian Journal of Developmental Biology, published by PLEIADES PUBLISHING INC, serves as a significant platform for researchers and professionals engaged in the field of developmental biology. With the ISSN 1062-3604 and E-ISSN 1608-3326, this journal focused on intricate biological processes and dynamic developmental mechanisms from 2005 until 2017. Although its coverage is currently discontinued in Scopus, it remains notable for its contribution to understanding the pivotal roles of biochemistry and molecular genetics within the context of development. As a publication situated in the competitive quartiles of the field and boasting an influential Scopus rank of #77 out of #78, it has made a unique mark in developmental studies. Researchers and academics seeking to enhance their knowledge of historical advancements in the discipline will find the journal a valuable resource, even as it navigates the transition away from active publication.

MOLECULAR MEDICINE

Transforming Knowledge into Clinical Solutions
Publisher: SPRINGERISSN: 1076-1551Frequency: 1 issue/year

MOLECULAR MEDICINE, published by SPRINGER, is a leading scholarly journal dedicated to advancing the fields of genetics and molecular biology with a focus on clinical applications. Since its inception in 1994, it has evolved to become a pivotal platform for disseminating innovative research findings, achieving a remarkable Q1 ranking in multiple categories, including Genetics, Molecular Biology, and Molecular Medicine as of 2023. Featuring an Open Access model since 2000, the journal ensures that cutting-edge research is freely available to the global scientific community, facilitating collaboration and knowledge exchange. With a commitment to high-quality peer-reviewed content, MOLECULAR MEDICINE serves as an essential resource for researchers, healthcare professionals, and students seeking to stay at the forefront of molecular research and its implications for medical science. For those interested in contributing to or accessing vital research in this dynamic field, MOLECULAR MEDICINE stands out as a premier choice.

ACTA HISTOCHEMICA

Illuminating Cell Structures Through Rigorous Histochemical Study
Publisher: ELSEVIER GMBHISSN: 0065-1281Frequency: 8 issues/year

ACTA HISTOCHEMICA, a prestigious journal published by Elsevier GmbH, is dedicated to advancing the field of histochemistry and its applications within cell biology and medicine. With an ISSN of 0065-1281 and an E-ISSN of 1618-0372, the journal provides a critical platform for the dissemination of high-quality research findings and reviews, integral for both emerging and established scholars. Since its inception in 1954 and continuing through to 2024, ACTA HISTOCHEMICA has maintained a strong commitment to publishing significant advancements in histology and cell biology, as evidenced by its categorization in Q3 for Cell Biology and Histology, as well as Q2 in miscellaneous medicine for the year 2023. The journal ranks favorably in Scopus, holding the 27th rank in Histology and a 200th rank in Cell Biology, highlighting its importance to the academic community. With its headquarters in Munich, Germany, ACTA HISTOCHEMICA continues to attract contributions from global researchers, fostering an international dialogue essential for the growth of knowledge in histochemistry and related disciplines.

CELL PROLIFERATION

Bridging Knowledge Gaps in Cell Proliferation Studies
Publisher: WILEYISSN: 0960-7722Frequency: 12 issues/year

CELL PROLIFERATION, published by Wiley, is a leading open-access journal that has been at the forefront of research since its inception in 1968. With an impact factor that solidifies its position in the Q1 category of both Cell Biology and Medicine (Miscellaneous), this journal serves as a premier platform for disseminating groundbreaking studies in the field of cellular and molecular biology. The journal is renowned for its rigorous peer-review process and comprehensive coverage of topics related to cell growth, division, and differentiation, making it an invaluable resource for researchers, professionals, and students alike. With its notable Scopus ranking of #30 in Biochemistry, Genetics, and Molecular Biology: Cell Biology, and a robust open access model since 2019, CELL PROLIFERATION ensures that cutting-edge research is accessible to a global audience, fostering collaboration and innovation across the scientific community. Located in the United Kingdom, the journal remains committed to enhancing the understanding of cellular processes, thereby influencing developments in medicine and biotechnology.

Cell Stem Cell

Transforming Knowledge into Innovation in Stem Cell Science
Publisher: CELL PRESSISSN: 1934-5909Frequency: 12 issues/year

Cell Stem Cell, published by CELL PRESS, is a premier journal at the forefront of cellular biology, genetics, and molecular medicine. With an esteemed impact factor and recognized as a Q1 journal in multiple categories including Cell Biology, Genetics, and Molecular Medicine, it offers researchers, professionals, and students rigorous, peer-reviewed articles that shape the future of stem cell research and regenerative medicine. Located in Cambridge, MA, this journal has become an invaluable resource since its inception in 2007 and is committed to disseminating groundbreaking findings that drive innovation and understanding in these critical fields. By consistently ranking within the top percentile of its categories in Scopus, Cell Stem Cell remains an essential platform for scholarly communication, fostering collaboration among leading scientists worldwide. Although the journal does not currently offer open access options, its comprehensive insights are pivotal for anyone engaged in the study of stem cells and their applications.

Cell and Bioscience

Connecting Researchers to Transformative Discoveries
Publisher: BMCISSN: Frequency: 1 issue/year

Cell and Bioscience is a prestigious open-access journal published by BMC that has been at the forefront of biochemistry, genetics, and molecular biology since its inception in 2011. With an impressive impact factor, this journal has established itself as a vital resource for researchers and professionals in these rapidly advancing fields, reflecting its high ranking of #29 out of 221 in the Scopus classification and placing it in the 87th percentile. Based in the United Kingdom, Cell and Bioscience aims to foster innovation and dissemination of research findings addressing critical biological questions through rigorous peer-reviewed articles and inter-disciplinary approaches. The journal's open-access model ensures unrestricted access to transformative research, promoting collaboration and knowledge sharing among academics, students, and practitioners worldwide. With a commitment to maintaining excellence in the field, Cell and Bioscience provides an essential platform for those looking to contribute to the evolving landscape of biosciences.

Stem Cell Reports

Illuminating the Path of Stem Cell Exploration
Publisher: CELL PRESSISSN: 2213-6711Frequency: 12 issues/year

Stem Cell Reports, published by CELL PRESS, is a distinguished open access journal that has been providing critical insights into the dynamic field of stem cell research since its launch in 2013. With a focus on advancing knowledge in Biochemistry, Cell Biology, Developmental Biology, and Genetics, the journal holds a prestigious Q1 ranking across these categories in 2023, underscoring its significant impact and leadership within the scientific community. The journal occupies a prominent position in the Scopus rankings, notably achieving a remarkable percentile ranking in multiple disciplines, which reflects its rigorous peer-review process and the high quality of the research it disseminates. Accessible to a global audience, Stem Cell Reports not only facilitates the open exchange of innovative findings but also serves as a pivotal resource for researchers, professionals, and students dedicated to exploring the potential of stem cells in regenerative medicine and biotechnology. The journal is committed to supporting the advancement of the field by showcasing groundbreaking research and fostering collaboration among scientists worldwide.

DIFFERENTIATION

Advancing the Frontiers of Cellular Understanding
Publisher: ELSEVIER SCI LTDISSN: 0301-4681Frequency: 6 issues/year

DIFFERENTIATION is a respected peer-reviewed journal published by Elsevier Science Ltd, dedicated to advancing knowledge in the fields of Cancer Research, Cell Biology, Developmental Biology, and Molecular Biology. With an established history since 1973, the journal continuously explores the intricacies of cellular and molecular processes that govern differentiation in biological systems, thus playing a pivotal role in shaping contemporary research directions. Currently indexed in the Q3 quartile across multiple relevant categories, it provides a crucial platform for researchers to disseminate their findings and engage with the scientific community. DIFFERENTIATION does not offer open access, but it remains a valuable resource for academics seeking to enhance their understanding of the fundamental mechanisms that underpin life sciences. By fostering a rigorous dialogue among scientists, it contributes significantly to the ever-evolving landscape of biochemistry and genetics.